News
![Tafinlar](/sites/default/files/styles/x_large/public/2023-12/tafinlar-960-540.jpg?itok=pHLj9SNH)
Daiichi Sankyo unit claims $182m in Novartis patent dispute
Novartis has settled a lawsuit brought by Daiichi Sankyo’s Plexxikon subsidiary, paying $180 million to resolve claims that its Tafinlar cancer drug infringed US patents h